Amalgamated Bank Pmv Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.51 - $3.12 $3,249 - $6,714	-2,152 Reduced 62.72%	1,279 $2,000
Q4 2023 Feb 06, 2024	SELL	$1.23 - $6.6 $467 - $2,508	-380 Reduced 9.97%	3,431 $11,000
Q1 2023 May 02, 2023	SELL	$4.77 - $9.16 $4,073 - $7,822	-854 Reduced 18.31%	3,811 $18,000
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $3,636 - $8,837	394 Added 9.23%	4,665 $66,000
Q1 2022 Jun 30, 2022	BUY	$14.86 - $23.55 $63,467 - $100,582	4,271 New	4,271 $89,000

42.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $65.7M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.